Nalpac Issues Voluntary Nationwide Recall of DTF Sexual Chocolate Due to the Presence of the Pharmaceutical Ingredient’s Sildenafil and Tadalafil
Nalpac has initiated a voluntary nationwide recall of DTF Sexual Chocolate after testing revealed the presence of the undeclared pharmaceutical ingredients sildenafil and tadalafil.
This recall affects Nalpac, its distributors, and compliance professionals overseeing dietary supplements or functional food products containing undeclared prescription drug components.
The presence of phosphodiesterase (PDE-5) inhibitors in products marketed as food or supplements constitutes a regulatory violation and a safety risk, particularly due to potential contraindications with nitrates. This underscores the risk profile for third-party resellers who may be liable for the integrity of products purchased for distribution. Regulatory teams may view this as an indicator of a continuing trend of pharmaceutical adulteration in the 'sexual enhancement' product category.
QA and procurement teams should audit suppliers of specialty food items to ensure robust screening for undeclared active pharmaceutical ingredients. Regulatory departments should confirm that any recalled inventory is quarantined and documented according to standard recall procedures.
FOR IMMEDIATE RELEASE – Date – Ferndale, Michigan. Nalpac is voluntarily recalling DTF Sexual Chocolate it purchased and resold. The products have been found to contain sildenafil and tadalafil.
Open in openFDA / FDA.gov